Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Front Immunol ; 13: 762580, 2022.
Article in English | MEDLINE | ID: mdl-35185872

ABSTRACT

Ankylosing spondylitis (AS) is a systemic, chronic, and inflammatory autoimmune disease associated with the disorder of intestinal microbiota. Unfortunately, effective therapies for AS are lacking. Recent evidence has indicated that indole-3-acetic acid (IAA), an important microbial tryptophan metabolite, can modulate intestinal homeostasis and suppress inflammatory responses. However, reports have not examined the in vivo protective effects of IAA against AS. In this study, we investigated the protective effects and underlying mechanisms through which IAA acts against AS. We constructed a proteoglycan (PG)-induced AS mouse model and administered IAA (50 mg/kg body weight) by intraperitoneal injection daily for 4 weeks. The effects of IAA on AS mice were evaluated by examining disease severity, intestinal barrier function, aryl hydrocarbon receptor (AhR) pathway, T-helper 17 (Th17)/T regulatory (Treg) balance, and inflammatory cytokine levels. The intestinal microbiota compositions were profiled through whole-genome sequencing. We observed that IAA decreased the incidence and severity of AS in mice, inhibited the production of pro-inflammatory cytokines (tumor necrosis factor α [TNF-α], interleukin [IL]-6, IL-17A, and IL-23), promoted the production of the anti-inflammatory cytokine IL-10, and reduced the ratios of pro-/anti- inflammatory cytokines. IAA ameliorated pathological changes in the ileum and improved intestinal mucosal barrier function. IAA also activated the AhR pathway, upregulated the transcription factor forehead box protein P3 (FoxP3) and increased Treg cells, and downregulated the transcription factors retinoic acid receptor-related orphan receptor gamma t (RORγt) and signal transducer and activator of transcription 3 (STAT3) and decreased Th17 cells. Furthermore, IAA altered the composition of the intestinal microbiota composition by increasing Bacteroides and decreasing Proteobacteria and Firmicutes, in addition to increasing the abundances of Bifidobacterium pseudolongum and Mucispirillum schaedleri. In conclusion, IAA exerted several protective effects against PG-induced AS in mice, which was mediated by the restoration of balance among the intestinal microbial community, activating the AhR pathway, and inhibiting inflammation. IAA might represent a novel therapeutic approach for AS.


Subject(s)
Gastrointestinal Microbiome/drug effects , Indoleacetic Acids/pharmacology , Spondylitis, Ankylosing/drug therapy , Spondylitis, Ankylosing/pathology , Animals , Anti-Inflammatory Agents/pharmacology , Cytokines/metabolism , Disease Models, Animal , Female , Intestinal Mucosa/metabolism , Mice , Mice, Inbred BALB C , Proteoglycans/toxicity , Spondylitis, Ankylosing/chemically induced , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology
2.
J Biomed Mater Res A ; 109(12): 2506-2515, 2021 12.
Article in English | MEDLINE | ID: mdl-34110080

ABSTRACT

ß-1,3-D-glucan has been reported to have a series of bioactivities including antitumor, antimicrobial, anti-inflammatory and antioxidative effects; however, its insolubility in neutral aqueous solution significantly restricts the potential application in biological and medicine fields. Herein, a water-soluble aminated ß-1,3-D-glucan (AG) was synthesized and the anti-inflammatory effect, cytotoxicity and plasmid DNA (pDNA) binding capacity of AG, serum stability, the particle sizes and zeta potentials of AG/pDNA nanocomposites, and the transfection efficiency and mechanism of action were studied. AG shows no obvious cytotoxicity within the range of working concentration (1-64 µg/ml) and it exerts potent anti-inflammatory effect independent on Dectin-1 and TLR2. AG/pDNA nanocomposites prepared by electrostatic interaction possess an appropriate particle size ranged from 192.8 to 118.4 nm and zeta potentials ranged from 20.880 to 27.16 mV with the N/P ratios from 5 to 100. AG/pDNA nanocomposites at the N/P ratios of 10 and 20 were able to show superior transfection efficiencies in RAW 264.7 cells as a result of their suitable particle size, zeta potential, anti-inflammatory effect, and the specific interaction with pattern recognition receptors (Dectin-1 and TLR2). These results indicate that AG is a potential candidate for DNA delivery system due to its potent anti-inflammatory effect and high transfection efficiency.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Drug Carriers , Genetic Therapy/methods , Proteoglycans/chemistry , Proteoglycans/pharmacology , Transfection/methods , Animals , Cell Survival/drug effects , DNA/metabolism , Gene Transfer Techniques , Lectins, C-Type/metabolism , Mice , Nanocomposites , Particle Size , Plasmids/genetics , Proteoglycans/toxicity , RAW 264.7 Cells , Toll-Like Receptor 2/metabolism
3.
FASEB J ; 33(9): 10116-10125, 2019 09.
Article in English | MEDLINE | ID: mdl-31211931

ABSTRACT

Colon organoids (colonoids) are known to be similar to colon tissue in structure and function, which makes them useful in the treatment of intestinal de-epithelialized disease. Matrigel, which is used as a transplantation scaffold for colonoids, cannot be used in clinical applications because of its undefined composition and tumorigenicity. This study identifies clinically available scaffolds that are effective for colonoid transplantation in damaged intestinal mucosa. The colon crypt was isolated and cultured from C57BL/6-Tg[CAG enhanced green fluorescent protein (EGFP)131Osb/LeySopJ mice into EGFP + colonoids and subsequently transplanted into the EDTA colitis mouse model using gelatin, collagen, or fibrin glue scaffolds. To identify scaffolds suitable for colonoid engraftment in injured colon mucosa, the success rates of transplantation and secondary EGFP colonoid formation were measured, and the scaffolds' mediated toxicity in vitro and in vivo was observed in recipient mice. When colonoids were transplanted with gelatin, collagen, and fibrin glue into the EDTA colitis mouse model, all groups were found to be successfully engrafted. Fibrin glue, especially, showed significant increase in the engrafted area compared with Matrigel after 4 wk. The scaffolds used in the study did not induce colonic toxicity after transplantation into the recipients' colons and were thus deemed safe when locally administrated. This study suggests new methods for and provides evidence of the safety and utility of the clinical application of colonoid-based therapeutics. Furthermore, the methods introduced in this study will be helpful in developing cell treatment using the esophagus or a stomach organoid for various digestive-system diseases.-Jee, J., Jeong, S. Y., Kim, H. K., Choi, S. Y., Jeong, S., Lee, J., Ko, J. S., Kim, M. S., Kwon, M.-S., Yoo, J. In vivo evaluation of scaffolds compatible for colonoid engraftments onto injured mouse colon epithelium.


Subject(s)
Colitis/therapy , Colon/injuries , Intestinal Mucosa/injuries , Organoids/transplantation , Tissue Scaffolds , Animals , Colitis/chemically induced , Collagen/toxicity , Drug Combinations , Edetic Acid/toxicity , Epithelium/injuries , Fibrin Tissue Adhesive , Gelatin , Genes, Reporter , Graft Survival , Laminin/toxicity , Male , Mice , Mice, Inbred C57BL , Organoids/cytology , Proteoglycans/toxicity , Tissue Scaffolds/adverse effects
4.
J Neuroinflammation ; 15(1): 335, 2018 Dec 03.
Article in English | MEDLINE | ID: mdl-30509328

ABSTRACT

OBJECTIVE: The regulatory role of capsaicin-sensitive peptidergic sensory nerves has been shown in acute inflammation, but little is known about their involvement in T/B-cell driven autoimmune arthritis. This study integratively characterized the function of these nerve endings in the proteoglycan-induced chronic arthritis (PGIA), a translational model of rheumatoid arthritis. METHODS: Peptidergic afferents were defunctionalized by resiniferatoxin (RTX) pretreatment in BALB/c mice, PGIA was induced by repeated antigen challenges. Hind paw volume, arthritis severity, grasping ability and the mechanonociceptive threshold were monitored during the 17-week experiment. Myeloperoxidase activity, vascular leakage and bone turnover were evaluated by in vivo optical imaging. Bone morphology was assessed using micro-CT, the intertarsal small joints were processed for histopathological analysis. RESULTS: Following desensitization of the capsaicin-sensitive afferents, ankle edema, arthritis severity and mechanical hyperalgesia were markedly diminished. Myeloperoxidase activity was lower in the early, but increased in the late phase, whilst plasma leakage and bone turnover were not altered. Desensitized mice displayed similar bone spurs and erosions, but increased trabecular thickness of the tibia and bony ankylosis of the spine. Intertarsal cartilage thickness was not altered in the model, but desensitization increased this parameter in both the non-arthritic and arthritic groups. CONCLUSION: This is the first integrative in vivo functional and morphological characterization of the PGIA mouse model, wherein peptidergic afferents have an important regulatory function. Their overall effect is proinflammatory by increasing acute inflammation, immune cell activity and pain. Meanwhile, their activation decreases spinal ankylosis, arthritis-induced altered trabecularity, and cartilage thickness in small joints.


Subject(s)
Arthritis, Rheumatoid/chemically induced , Arthritis, Rheumatoid/pathology , Capsaicin/pharmacology , Proteoglycans/toxicity , Sensory System Agents/pharmacology , Sensory Thresholds/drug effects , Animals , Ankle/diagnostic imaging , Cartilage/pathology , Disease Models, Animal , Diterpenes/pharmacology , Female , Hindlimb/drug effects , Hindlimb/physiopathology , Mice , Mice, Inbred BALB C , Neurotoxins/pharmacology , Peptides/metabolism , Reactive Oxygen Species/metabolism , Severity of Illness Index , Spine/diagnostic imaging
5.
J Biomater Appl ; 33(4): 541-552, 2018 10.
Article in English | MEDLINE | ID: mdl-30326800

ABSTRACT

Understanding the structure-function relationship in biomaterial constructs is critical in optimizing biological outcomes. For ensheathed structures such as peripheral nerve, engineering implantable tissue substitutes has been challenging. This is due to a unique geometry of thin-walled microtube arrays composed mostly of basement membrane. In this work, we propose a sacrificial templating method to create Matrigel scaffolds that resemble endogenous peripheral nerve. These paralleled microtube constructs possess high void space and membrane-like walls. Additionally, we investigated the effect of chemical crosslinking in altering the physical, mechanical, and biologic properties of Matrigel. Results show that both glutaraldehyde and genipin increased the modulus and failure stress of Matrigel while also improving degradation resistance. However, glutaraldehyde crosslinking induced some cytotoxicity whereas genipin showed good biocompatibility. PC-12 cells, Schwann cells, and primary chick dorsal root ganglia cultured onto microtube scaffolds demonstrated viability up to 10 days. Strong cellular alignment along the channels was observed in Schwann cells whereas neurite outgrowth in primary chick dorsal root ganglia was also biased along the major axis of the microtubes. This suggests that the microtubes may mediate cell orientation and axon pathfinding. This proof of concept study provides a tunable workflow that may be adapted to other collagen types.


Subject(s)
Biocompatible Materials/chemistry , Collagen/chemistry , Laminin/chemistry , Peripheral Nerve Injuries/therapy , Proteoglycans/chemistry , Tissue Scaffolds/chemistry , Biocompatible Materials/toxicity , Cell Survival , Cells, Cultured , Collagen/toxicity , Cross-Linking Reagents/chemistry , Drug Combinations , Ganglia, Spinal/cytology , Glutaral/chemistry , Laminin/toxicity , Nerve Regeneration , Polyesters/chemistry , Proof of Concept Study , Proteoglycans/toxicity , Schwann Cells/cytology , Tissue Engineering
6.
BMC Musculoskelet Disord ; 18(1): 228, 2017 05 30.
Article in English | MEDLINE | ID: mdl-28558827

ABSTRACT

BACKGROUND: Ankylosing spondylitis (AS) is characterised by immune-mediated arthritis and osteoproliferation, ultimately leading to joint ankylosis. Whether inflammation is necessary for osteoproliferation is controversial, fuelled by the unclear efficacy of anti-inflammatory treatments on radiographic progression. In proteoglycan-induced spondylitis (PGISp), a mouse model of AS, inflammation is the prerequisite for osteoproliferation as osteoproliferation was only observed following inflammation-driven intervertebral disc (IVD) destruction. We hypothesised that early intervention with a potent anti-inflammatory therapy would protect IVD integrity and consequently alter disease progression. METHODS: PGISp mice received vehicle or a combination of etanercept (ETN) plus prednisolone (PRD) therapy for 2 or 6 weeks initiated at an early disease stage. Peripheral arthritis was scored longitudinally. Spinal disease was assessed using a semi-quantitative histological scoring regimen including inflammation, joint destruction and excessive tissue formation. RESULTS: ETN + PRD therapy significantly delayed the onset of peripheral arthritis. IVD integrity was significantly protected when treatment was commenced in early disease. Six-weeks of treatment resulted in trends towards reductions in intervertebral joint damage and excessive tissue formation. IVD score distribution was dichotomized, likely reflecting the extent of axial disease at initiation of therapy. In the sub-group of mice with high IVD destruction scores, ETN + PRD treatment significantly reduced IVD destruction severity, inflammation and bone erosion and reduced cartilage damage and excessive tissue formation. CONCLUSIONS: Early intervention with anti-inflammatory treatment not only improved inflammatory symptoms but also ameliorated structural damage of spine in PGISp mice. This preclinical observation suggests that early anti-inflammatory intervention may slow radiographic progression in AS patients.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Disease Models, Animal , Proteoglycans/toxicity , Spondylitis, Ankylosing/chemically induced , Spondylitis, Ankylosing/drug therapy , Animals , Drug Administration Schedule , Drug Therapy, Combination , Etanercept/administration & dosage , Female , Humans , Mice , Mice, Inbred BALB C , Prednisolone/administration & dosage , Spondylitis, Ankylosing/pathology
7.
Pain ; 158(1): 161-170, 2017 01.
Article in English | MEDLINE | ID: mdl-27992393

ABSTRACT

Bladder pain syndrome (BPS) is associated with breakdown of the protective uroepithelial barrier of the urinary bladder allowing urinary constituents access to bladder sensory neurons. Although there are several animal models of cystitis, none specifically relates to BPS. Here, we aimed to create such a model using enzymatic digestion of the barrier proteoglycans (PGs) in the rat. Twenty female Wistar rats were anaesthetized and transurethrally catheterized. Ten animals were treated with 0.25IU of intravesical chondroitinase ABC and heparanase III to digest chondroitin sulphate and heparin sulphate PGs, respectively. Ten animals received saline. Following PG deglycosylation, bladders showed irregular loss of the apical uroplakin and a significant increase in neutrophils, not evident in the control group. Spinal cord sections were also collected for c-fos analysis. A large and significant increase in fos immunoreactivity in the L6/S1 segments in the treatment vs control bladders was observed. Cystometry was performed on 5 treatment and 5 control animals. Analysis revealed a significant increase in micturition reflex excitability postdeglycosylation. On a further group of 10 animals, von Frey mechanical withdrawal thresholds were tested on abdominal skin before and after PG digestions. There was a significant decrease in abdominal mechanical withdrawal threshold postdeglycosylation compared with controls. The results of this animal study suggest that many of the clinical features of BPS are seen after PG digestion from the bladder lumen. This model can be used to further understand mechanisms of pain in patients with BPS and to test new therapeutic strategies.


Subject(s)
Extracellular Matrix/metabolism , Pain/etiology , Pain/metabolism , Urinary Bladder Diseases/complications , Animals , Capsaicin/toxicity , Chondroitin ABC Lyase/toxicity , Disease Models, Animal , Female , Glucuronidase/toxicity , Glycosylation/drug effects , Neutrophil Infiltration/drug effects , Proteoglycans/toxicity , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord/metabolism , Urinary Bladder/drug effects , Urinary Bladder/physiology , Urinary Bladder Diseases/chemically induced
8.
PLoS One ; 11(7): e0160284, 2016.
Article in English | MEDLINE | ID: mdl-27466816

ABSTRACT

BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease affecting the joints. Anti-citrullinated protein antibodies (ACPA) are frequently found in RA. Previous studies identified a citrullinated epitope in cartilage proteoglycan (PG) aggrecan that elicited pro-inflammatory cytokine production by RA T cells. We recently reported the presence of ACPA-reactive (citrullinated) PG in RA cartilage. Herein, we sought to identify additional citrullinated epitopes in human PG that are recognized by T cells or antibodies from RA patients. METHODS: We used mice with PG-induced arthritis (PGIA) as a screening tool to select citrulline (Cit)-containing PG peptides that were more immunogenic than the arginine (R)-containing counterparts. The selected peptide pairs were tested for induction of pro-inflammatory T-cell cytokine production in RA and healthy control peripheral blood mononuclear cell (PBMC) cultures using ELISA and flow cytometry. Anti-Cit and anti-R peptide antibodies were detected by ELISA. RESULTS: Splenocytes from mice with PGIA exhibited greater T-cell cytokine secretion in response to the Cit than the R version of PG peptide 49 (P49) and anti-P49 antibodies were found in PGIA serum. PBMC from ACPA+ and ACPA- RA patients, but not from healthy controls, responded to Cit49 with robust cytokine production. High levels of anti-Cit49 antibodies were found in the plasma of a subset of ACPA+ RA patients. Another PG peptide (Cit13) similar to the previously described T-cell epitope induced greater cytokine responses than R13 by control (but not RA) PBMC, however, anti-Cit13 antibodies were rarely detected in human plasma. CONCLUSIONS: We identified a novel citrullinated PG epitope (Cit49) that is highly immunogenic in mice with PGIA and in RA patients. We also describe T-cell and antibody reactivity with Cit49 in ACPA+ RA. As citrullinated PG might be present in RA articular cartilage, Cit PG epitope-induced T-cell activation or antibody deposition may occur in the joints of RA patients.


Subject(s)
Aggrecans/metabolism , Arthritis, Experimental/immunology , Arthritis, Rheumatoid/immunology , Citrulline/metabolism , Epitopes/immunology , Proteoglycans/toxicity , Aggrecans/immunology , Amino Acid Sequence , Animals , Arthritis, Experimental/chemically induced , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Case-Control Studies , Cell Proliferation , Cells, Cultured , Cytokines/biosynthesis , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Epitopes/chemistry , Flow Cytometry , Humans , Mice , Proteoglycans/chemistry , Spleen/cytology , Spleen/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology
9.
Mol Cells ; 38(7): 663-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26159216

ABSTRACT

hBMSCs are multipotent cells that are useful for tissue regeneration to treat degenerative diseases and others for their differentiation ability into chondrocytes, osteoblasts, adipocytes, hepatocytes and neuronal cells. In this study, biodegradable elastic hydrogels consisting of hydrophilic poly(ethylene glycol) (PEG) and hydrophobic poly(ε-caprolactone) (PCL) scaffolds were evaluated for tissue engineering because of its biocompatibility and the ability to control the release of bioactive peptides. The primary cultured cells from human bone marrow are confirmed as hBMSC by immunohistochemical analysis. Mesenchymal stem cell markers (collagen type I, fibronectin, CD54, integrin1ß, and Hu protein) were shown to be positive, while hematopoietic stem cell markers (CD14 and CD45) were shown to be negative. Three different hydrogel scaffolds with different block compositions (PEG:PCL=6:14 and 14:6 by weight) were fabricated using the salt leaching method. The hBMSCs were expanded, seeded on the scaffolds, and cultured up to 8 days under static conditions in Iscove's Modified Dulbecco's Media (IMDM). The growth of MSCs cultured on the hydrogel with PEG/PCL= 6/14 was faster than that of the others. In addition, the morphology of MSCs seemed to be normal and no cytotoxicity was found. The coating of the vascular endothelial growth factor (VEGF) containing scaffold with Matrigel slowed down the release of VEGF in vitro and promoted the angiogenesis when transplanted into BALB/c nude mice. These results suggest that hBMSCs can be supported by a biode gradable hydrogel scaffold for effective cell growth, and enhance the angiogenesis by Matrigel coating.


Subject(s)
Collagen/metabolism , Laminin/metabolism , Mesenchymal Stem Cells/metabolism , Neovascularization, Physiologic , Polyesters/metabolism , Polyethylene Glycols/metabolism , Proteoglycans/metabolism , Vascular Endothelial Growth Factor A/metabolism , Animals , Bone Marrow/metabolism , Cell Transplantation , Cells, Cultured , Collagen/toxicity , Drug Combinations , Humans , Hydrogels/metabolism , Hydrogels/toxicity , Laminin/toxicity , Mesenchymal Stem Cells/cytology , Mice, Inbred BALB C , Polyesters/toxicity , Polyethylene Glycols/toxicity , Proteoglycans/toxicity
10.
Ann Rheum Dis ; 74(4): 769-77, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24395558

ABSTRACT

OBJECTIVES: To explore the immunosuppressive effect and mechanism of action of intraperitoneal (ip) and intra-articular (ia) mesenchymal stem cell (MSC) injection in proteoglycan induced arthritis (PGIA). METHODS: MSC were administered ip or ia after establishment of arthritis. We used serial bioluminescence imaging (BLI) to trace luciferase-transfected MSC. Mice were sacrificed at different time points to examine immunomodulatory changes in blood and secondary lymphoid organs. RESULTS: Both ip and local ia MSC injection resulted in a beneficial clinical and histological effect on established PGIA. BLI showed that MSC ip and ia in arthritic mice are largely retained for several weeks in the peritoneal cavity or injected joint respectively, without signs of migration. Following MSC treatment pathogenic PG-specific IgG2a antibodies in serum decreased. The Th2 cytokine IL-4 was only upregulated in PG-stimulated lymphocytes from spleens in ip treated mice and in lymphocytes from draining lymph nodes in ia treated mice. An increase in production of IL-10 was seen with equal distribution. Although IFN-γ was also elevated, the IFN-γ/IL-4 ratio in MSC treated mice was opposite to the ratio in (untreated) active PGIA. CONCLUSIONS: MSC treatment, both ip and ia, suppresses PGIA, a non-collagen induced arthritis model. MSC are largely retained for weeks in the injection region. MSC treatment induced at the region of injection a deviation of PG-specific immune responses, suggesting a more regulatory phenotype with production of IL-4 and IL-10, but also of IFN-γ, and a systemic decrease of pathogenic PG-specific IgG2a antibodies. These findings underpin the potential of MSC treatment in resistant arthritis.


Subject(s)
Arthritis, Experimental/therapy , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/immunology , Animals , Antibodies/immunology , Arthritis, Experimental/chemically induced , Female , Immune Tolerance/immunology , Immunoglobulin G/immunology , Injections, Intra-Articular , Injections, Intraperitoneal , Interferon-gamma/immunology , Interleukin-4/immunology , Luminescent Measurements , Mesenchymal Stem Cells/metabolism , Mice , Mice, Inbred BALB C , Proteoglycans/immunology , Proteoglycans/toxicity , Spleen/cytology , Spleen/immunology
11.
Brain ; 136(Pt 9): 2859-75, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23983033

ABSTRACT

Globoid cell leukodystrophy (Krabbe disease) is a neurological disorder of infants caused by genetic deficiency of the lysosomal enzyme ß-galactosylceramidase leading to accumulation of the neurotoxic metabolite 1-ß-d-galactosylsphingosine (psychosine) in the central nervous system. Angiogenesis plays a pivotal role in the physiology and pathology of the brain. Here, we demonstrate that psychosine has anti-angiogenic properties by causing the disassembling of endothelial cell actin structures at micromolar concentrations as found in the brain of patients with globoid cell leukodystrophy. Accordingly, significant alterations of microvascular endothelium were observed in the post-natal brain of twitcher mice, an authentic model of globoid cell leukodystrophy. Also, twitcher endothelium showed a progressively reduced capacity to respond to pro-angiogenic factors, defect that was corrected after transduction with a lentiviral vector harbouring the murine ß-galactosylceramidase complementary DNA. Finally, RNA interference-mediated ß-galactosylceramidase gene silencing causes psychosine accumulation in human endothelial cells and hampers their mitogenic and motogenic response to vascular endothelial growth factor. Accordingly, significant alterations were observed in human microvasculature from brain biopsy of a globoid cell leukodystrophy case. Together these data demonstrate that ß-galactosylceramidase deficiency induces significant alterations in endothelial neovascular responses that may contribute to central nervous system and systemic damages that occur in globoid cell leukodystrophy.


Subject(s)
Leukodystrophy, Globoid Cell/complications , Neovascularization, Pathologic/etiology , Neovascularization, Pathologic/pathology , Animals , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Aorta/pathology , Aorta/ultrastructure , Biocompatible Materials , Brain/drug effects , Brain/pathology , Brain/ultrastructure , Cattle , Cell Movement/drug effects , Cell Movement/genetics , Chorioallantoic Membrane/drug effects , Chorioallantoic Membrane/metabolism , Collagen/toxicity , Disease Models, Animal , Drug Combinations , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Fibroblast Growth Factor 2/pharmacology , Green Fluorescent Proteins/metabolism , Humans , Laminin/toxicity , Leukodystrophy, Globoid Cell/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron, Transmission , Neovascularization, Pathologic/prevention & control , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Proteoglycans/toxicity , Psychosine/metabolism , Psychosine/pharmacology , RNA, Small Interfering/administration & dosage , Time Factors , Transfection , Umbilical Veins/cytology , Vascular Endothelial Growth Factor A/pharmacology , Vascular Endothelial Growth Factor Receptor-2/genetics , Vascular Endothelial Growth Factor Receptor-2/metabolism , Zonula Occludens-1 Protein
12.
PLoS One ; 8(7): e67495, 2013.
Article in English | MEDLINE | ID: mdl-23840873

ABSTRACT

The long term in vivo biocompatibility is an essential feature for the design and development of sustained drug release carriers. In the recent intraocular drug delivery studies, hydrogels were suggested as sustained release carriers. The biocompatibility test for these hydrogels, however, was commonly performed only through in vitro cell culture examination, which is insufficient before the clinical applications. We compared three thermosensitive hydrogels that have been suggested as the carriers for drugs by their gel-solution phase-change properties. A new block terpolymer (PEOz-PCL-PEOz, ECE) and two commercial products (Matrigel® and Pluronic F127) were studied. The results demonstrated that the ocular media remained translucent for ECE and Pluronic F127 in the first 2 weeks, but cataract formation for Matrigel occurred in 2 weeks and for Pluronic F127 in 1 month, while turbid media was observed for both Matrigel and Pluronic F127 in 2 months. The electrophysiology examinations showed significant neuroretinal toxicity of Matrigel and Pluronic F127 but good biocompatibility of ECE. The neuroretinal toxicity of Matrigel and Pluronic F127 and superior biocompatibility of ECE hydrogel suggests ECE as more appropriate biomaterial for use in research and potentially in intraocular application.


Subject(s)
Biocompatible Materials/toxicity , Collagen/toxicity , Drug Carriers/toxicity , Hydrogels/toxicity , Laminin/toxicity , Poloxamer/toxicity , Polyamines/toxicity , Polyesters/toxicity , Proteoglycans/toxicity , Animals , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , Collagen/administration & dosage , Collagen/chemistry , Drug Carriers/administration & dosage , Drug Carriers/chemistry , Drug Combinations , Female , Hydrogels/administration & dosage , Hydrogels/chemistry , Laminin/administration & dosage , Laminin/chemistry , Poloxamer/administration & dosage , Poloxamer/chemistry , Polyamines/administration & dosage , Polyamines/chemistry , Polyesters/administration & dosage , Polyesters/chemistry , Proteoglycans/administration & dosage , Proteoglycans/chemistry , Rabbits , Retina/drug effects , Retina/pathology
14.
Int J Med Mushrooms ; 13(3): 227-36, 2011.
Article in English | MEDLINE | ID: mdl-22135874

ABSTRACT

Turkey tail medicinal mushroom, Trametes versicolor (TV), is a species with a variety of pharmacological activities. Its intracellular polysaccharopeptides are widely commercialized. Recently, we found a novel TV strain LH-1 in Taiwan and demonstrated that the extracellular polysaccharopeptide (ePSP) of LH-1 obtained from submerged culture exhibits significant immunomodulatory activity. In this in vivo study, we further evaluated the safety of orally administered LH-1 ePSP using both male and female ICR mice. The LH-1 ePSP was orally administered to mice at levels of 0 (water), 100 (low dose), 500 (medium dose), or 1000 mg/kg/day (high dose) for 28 days. Clinical observations, growth, food consumption, histopathological examination, and clinical biochemical analyses revealed no adverse effects of LH-1 ePSP in mice. There were no significant differences in the results of target organ weights, hematological analyses, and urinalysis examination among groups. However, male mice that ingested high doses of LH-1 ePSP tended to have decreased lung weights and platelet numbers. In conclusion, the results of the present study suggested that oral administration of LH-1 ePSP for 28 days is accompanied by no obvious signs of toxicity. The lack of toxicity supports the potential use of LH-1 ePSP as a food or dietary supplement.


Subject(s)
Proteoglycans/toxicity , Trametes/chemistry , Administration, Oral , Animals , Blood Cell Count , Blood Chemical Analysis , Body Weight/drug effects , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Female , Immunomodulation/drug effects , Male , Mice , Mice, Inbred ICR , Organ Size/drug effects , Proteoglycans/administration & dosage , Random Allocation , Taiwan , Time Factors , Toxicity Tests , Trametes/classification , Trametes/isolation & purification , Urinalysis
15.
J Immunol ; 187(9): 4900-6, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21948985

ABSTRACT

The efficacy of B cell-depletion therapy in rheumatoid arthritis has driven interest in understanding the mechanism. Because the decrease in autoantibodies in rheumatoid arthritis does not necessarily correlate with clinical outcome, other mechanisms may be operative. We previously reported that in proteoglycan-induced arthritis (PGIA), B cell-depletion inhibits autoreactive T cell responses. Recent studies in B cell-depletion therapy also indicate a role for B cells in suppressing regulatory mechanisms. In this study, we demonstrate that B cells inhibited both the expansion and function of T regulatory (Treg) cells in PGIA. Using an anti-CD20 mAb, we depleted B cells from mice with PGIA and assessed the Treg cell population. Compared to control Ab-treated mice, Treg cell percentages were elevated in B cell-depleted mice, with a higher proportion of CD4(+) T cells expressing Foxp3 and CD25. On a per-cell basis, CD4(+)CD25(+) cells from B cell-depleted mice expressed increased amounts of Foxp3 and were significantly more suppressive than those from control Ab-treated mice. The depletion of Treg cells with an anti-CD25 mAb concurrent with B cell-depletion therapy restored the severity of PGIA to levels equal to untreated mice. Although titers of autoantibodies did not recover to untreated levels, CD4(+) T cell recall responses to the immunizing Ag returned as measured by T cell proliferation and cytokine production. Thus, B cells have the capacity to regulate inflammatory responses by enhancing effector T cells along with suppressing Treg cells.


Subject(s)
Arthritis, Experimental/immunology , Arthritis, Experimental/prevention & control , B-Lymphocyte Subsets/immunology , Lymphocyte Depletion , Lymphopenia/immunology , Lymphopenia/pathology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Animals , Arthritis, Experimental/pathology , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , Arthritis, Rheumatoid/prevention & control , B-Lymphocyte Subsets/pathology , Epitopes, T-Lymphocyte/immunology , Female , Inflammation/immunology , Inflammation/pathology , Lymphocyte Depletion/methods , Lymphopenia/genetics , Mice , Mice, Inbred BALB C , Mice, Knockout , Proteoglycans/administration & dosage , Proteoglycans/immunology , Proteoglycans/toxicity , Severity of Illness Index , T-Lymphocytes, Regulatory/pathology
16.
Int J Biol Macromol ; 48(3): 511-7, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21262260

ABSTRACT

Proteoglycan (P1) purified from Phellinus linteus has been reported to have anti-disease activities. The objectives of our research were to determine the anti-tumor effect and possible mechanisms of P1 on human cancer cells. Cell inhibition assay showed that P1 has an antiproliferative effect on HepG2, HT-29, NCI-H 460 and MCF-7 human colon cancer cells, especially it was very effective in inhibiting HT-29 cells. When HT-29-bearing mice were treated with P1(100mg/kg), there was relative increase in spleen and thymus weights, the plasmatic pIgR and IgA levels were significantly increased, also there was a notable decrease in plasmatic PGE2, Reg IV, EGFR and Akt concentrations measured by ELISA. RT-PCR analysis suggested that P1-induced HT-29 apoptosis appeared to be associated with a decrease in the levels of expression of Reg IV and EGFR. These results suggest that P1 might have two potential roles in treating cancer; it acts as an immunopotentiator partly through protecting T cells from escaping PGE2 attack and enhancing the mucosal IgA response, and as a direct inhibitor by disrupting the Reg IV/EGFR/Akt signaling pathway.


Subject(s)
Colorectal Neoplasms/pathology , ErbB Receptors/metabolism , Immunologic Factors/pharmacology , Lectins, C-Type/metabolism , Proteoglycans/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects , Animals , Antineoplastic Agents/pharmacology , Cell Cycle Proteins/genetics , Cell Line, Transformed , Cell Line, Tumor , Cell Proliferation/drug effects , Colorectal Neoplasms/drug therapy , DEAD-box RNA Helicases/genetics , ErbB Receptors/genetics , Female , HT29 Cells , Hep G2 Cells , Humans , Immunoglobulin A/blood , Immunologic Factors/toxicity , Lectins, C-Type/genetics , Mice , Mice, Inbred BALB C , Mice, Nude , Minichromosome Maintenance Complex Component 2 , Nuclear Proteins/genetics , Pancreatitis-Associated Proteins , Prostaglandins E/blood , Proteoglycans/toxicity , Xenograft Model Antitumor Assays
17.
Invest Ophthalmol Vis Sci ; 51(11): 6009-17, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20538989

ABSTRACT

PURPOSE: The exudative, or the wet form of age-related macular degeneration (AMD) is characterized by choroidal neovascularization (CNV). A subretinal Matrigel (BD Biosciences, Bedford MA) model of CNV is described here, along with the effects of vascular endothelial growth factor (VEGF) neutralization on the development of CNV and associated inflammation and fibrosis. METHODS: CNV was induced in adult Sprague-Dawley rats by subretinal injection of Matrigel. CNV growth and associated leukocyte infiltration and collagen deposition were examined. VEGF Trap (Regeneron Pharmaceuticals, Tarrytown, NY), a recombinant protein that comprises portions of the extracellular domains of VEGF receptors 1 and 2 and that binds all isoforms of VEGF-A as well as placental growth factor with high affinity, was administered subcutaneously. RESULTS: Initiation of CNV was detected 4 days after Matrigel injection and then increased progressively in size. Systemic administration of VEGF Trap beginning on day 2 and 6 completely prevented development of CNV. When CNV was allowed to develop for 10 days before treatment was initiated, VEGF Trap not only prevented its further progression, but also induced substantial regression of existing lesions. In addition, VEGF Trap treatment reduced the total lesion volume and largely prevented the progressive leukocyte infiltration and fibrosis associated with CNV. CONCLUSIONS: The subretinal Matrigel CNV model provides a convenient tool for the study of the diverse components of complex CNV lesions. The data not only confirm the critical roles of VEGF in the development and maintenance of CNV, but further demonstrate that VEGF and other VEGF receptor 1 ligands promote CNV-associated inflammation and fibrosis.


Subject(s)
Choroidal Neovascularization/chemically induced , Choroidal Neovascularization/prevention & control , Choroiditis/prevention & control , Collagen/toxicity , Disease Models, Animal , Laminin/toxicity , Proteoglycans/toxicity , Recombinant Fusion Proteins/administration & dosage , Vascular Endothelial Growth Factor A/metabolism , Actins/metabolism , Animals , Chemotaxis, Leukocyte/drug effects , Choroidal Neovascularization/metabolism , Choroidal Neovascularization/pathology , Collagen/metabolism , Drug Combinations , Fibrosis/prevention & control , Injections, Subcutaneous , Leukocyte Common Antigens/metabolism , Microscopy, Confocal , Rats , Rats, Sprague-Dawley , Receptors, Vascular Endothelial Growth Factor , Vimentin/metabolism
18.
Genes Immun ; 9(7): 591-601, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18650834

ABSTRACT

Proteoglycan (PG)-induced arthritis (PGIA) is an autoimmune inflammatory disease controlled by multiple genes in the murine genome. BALB/c x DBA/2 congenic strains carrying four major PGIA chromosome loci were immunized, and positions of loci on chromosomes 3, 7, 8 and 19 (loci Pgia26, Pgia21, Pgia4 and Pgia12, respectively) were confirmed. Each congenic strain exhibited a different pattern of regulation of clinical and immunologic features of PGIA, and these features were significantly influenced by gender. Locus Pgia26 delayed PGIA onset in males and females, and the effect was associated with a lower rate of antigen-induced lymphocyte proliferation and lower production of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-4 (IL-4). Pgia12 similarly delayed onset in males, but the effect was achieved by elevated proliferation of PG-specific lymphocytes and enhanced production of IFN-gamma and IL-4. The effect of the Pgia21 locus was arthritis-suppressive in females but PGIA-permissive in congenic males. These opposite effects are attributed to two-fold higher serum autoantibody and IL-6 levels in males than in females. Our study supports the idea that each congenic strain represents a different immunologic subtype of PGIA, providing an explanation for the complex etiology and various clinical phenotypes of rheumatoid arthritis.


Subject(s)
Arthritis, Experimental/genetics , Arthritis, Experimental/immunology , Models, Immunological , Phenotype , Animals , Arthritis, Experimental/chemically induced , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , Crosses, Genetic , Female , Inflammation Mediators/toxicity , Male , Mice , Mice, Congenic , Mice, Inbred BALB C , Mice, Inbred DBA , Proteoglycans/toxicity
19.
J Immunol ; 177(3): 1932-40, 2006 Aug 01.
Article in English | MEDLINE | ID: mdl-16849507

ABSTRACT

Proteoglycan (PG)-induced arthritis, a murine model of rheumatoid arthritis, is characterized by autoimmunity against mouse cartilage PG and chronic joint inflammation. L-selectin (CD62L) and CD44 are major adhesion molecules on leukocytes that regulate their homing to lymph nodes and entry into inflamed tissues. In the present study, we studied the requirement for CD44 and CD62L expression for mediating lymphocyte homing, thus permitting the development of autoimmunity vs mediating the entry of leukocytes into the joints, thus allowing inflammation in PG-induced arthritis. We immunized wild-type, CD44 knockout (KO), CD62L KO, and double (CD44/CD62L) KO BALB/c mice with PG and monitored the effects of gene deficiencies on PG-specific immunity, arthritis severity, leukocyte trafficking, and the ability of lymphocytes to adoptively transfer disease to syngeneic SCID mice. Single and double KO mice demonstrated reduced PG-specific spleen cell proliferation, but the production of Th cytokines and autoantibodies was comparable in KO and wild-type mice. KO leukocytes had reduced ability to adhere tightly to the synovial endothelium in arthritic joints. This diminished leukocyte adhesion correlated with the magnitude of granulocyte (neutrophil) influx and the severity of inflammation, which were both reduced in the joints of KO mice. However, transfer of spleen cells from mildly arthritic KO donors to SCID hosts resulted in development of severe arthritis. Our results indicate that CD44 and CD62L expression in the cells of the innate immune system (granulocytes) is important for their efficient influx into the joints and also suggest that granulocytes play a crucial role in arthritis progression.


Subject(s)
Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , Granulocytes/immunology , Hyaluronan Receptors/biosynthesis , L-Selectin/biosynthesis , Proteoglycans/toxicity , Synovitis/immunology , Synovitis/pathology , Animals , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/metabolism , Cell Adhesion/genetics , Cell Adhesion/immunology , Cell Movement/genetics , Cell Movement/immunology , Cell Proliferation , Cytokines/biosynthesis , Disease Models, Animal , Disease Progression , Epitopes/immunology , Female , Granulocytes/metabolism , Granulocytes/pathology , Humans , Hyaluronan Receptors/genetics , Hyaluronan Receptors/physiology , Immunity, Innate/genetics , L-Selectin/genetics , L-Selectin/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred DBA , Mice, Knockout , Mice, SCID , Proteoglycans/immunology , Severity of Illness Index , Synovitis/genetics , Synovitis/metabolism
20.
Ophthalmic Res ; 38(2): 71-3, 2006.
Article in English | MEDLINE | ID: mdl-16352919

ABSTRACT

This study presents a mouse model for human age-related macular degeneration (AMD) as characterized by subretinal deposit and choroidal neovascularization. Matrigel, a basement membrane extract, solidifies after implantation in tissue and can stimulate local angiogenesis. This study demonstrates the induction of neovascularization and focal retinal degeneration following subretinal Matrigel injection in mice. In senescent mice, the normal functioning of CC chemokine CCL2/MCP-1 and its receptor CCR2 confers protection against age-related retinal degeneration, a disease that shares many similar features with human AMD. Our data shows that CCL2-deficient mice develop more severe disease as compared to the wild-type controls. These findings suggest that Matrigel subretinal injection could be used to generate AMD-like pathological changes. The data support the previously proposed role of CCL2 in AMD pathogenesis.


Subject(s)
Biocompatible Materials/toxicity , Choroidal Neovascularization/chemically induced , Collagen/toxicity , Laminin/toxicity , Proteoglycans/toxicity , Retinal Degeneration/chemically induced , Animals , Biocompatible Materials/administration & dosage , Chemokine CCL2/deficiency , Choroidal Neovascularization/complications , Choroidal Neovascularization/pathology , Collagen/administration & dosage , Disease Models, Animal , Drug Combinations , Extracellular Matrix , Injections , Laminin/administration & dosage , Mice , Proteoglycans/administration & dosage , Retina , Retinal Degeneration/complications , Retinal Degeneration/pathology , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...